Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$22.4M | -$50.1M | -$56.1M | -$40.5M | -$73.6M | -$60.7M |
| Net income | -$15.0M | -$50.0M | -$53.8M | -$37.4M | -$70.5M | -$60.8M |
| EPS (diluted) | -$28.08 | -$10.94 | -$1.86 | -$1.05 | -$1.63 | -$1.33 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$18.6M | -$42.9M | -$40.6M | -$32.6M | -$56.2M | -$60.3M |
| Capital expenditures | $560K | $498K | $3.61M | $769K | $254K | $0.00 |
| Free cash flow | -$19.2M | -$43.4M | -$44.2M | -$33.4M | -$56.4M | -$60.3M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $92.6M | $158M | $129M | $134M | $111M | $57.0M |
| Total assets | $96.4M | $179M | $160M | $175M | $127M | $69.4M |
| Total liabilities | $7.18M | $26.5M | $37.9M | $63.5M | $53.5M | $44.6M |
| Long-term debt | — | — | — | $40.0M | $32.1M | $32.1M |
| Shareholders' equity | -$51.9M | $153M | $122M | $111M | $73.4M | $24.8M |
| Retained earnings | -$51.9M | -$253M | -$307M | -$344M | -$415M | -$475M |
| Shares (wtd avg diluted) | 1.00M | 18.5M | 28.9M | 35.6M | 43.9M | 46.8M |
Every figure is extracted from Werewolf Therapeutics, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.